ProShare Advisors’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-586
Closed -$398K 2019
2022
Q1
$398K Sell
586
-95
-14% -$57.2K ﹤0.01% 1446
2021
Q4
$470K Buy
681
+290
+74% +$214K ﹤0.01% 1496
2021
Q3
$290K Sell
391
-400
-51% -$273K ﹤0.01% 1580
2021
Q2
$593K Buy
+791
New +$605K ﹤0.01% 1406

Other funds holding OM

ProShare Advisors's OM Position: Q2 2022 in Review

ProShare Advisors sold out of Outset Medical (OM) in Q2 2022, closing a stake of 586 shares — an estimated $398K sold.

ProShare Advisors first reported a position in OM in Q2 2021 and held it in 4 quarters. The position peaked at $593K in Q2 2021. 149 funds tracked by Wall St. Rank hold OM as of Q2 2022.

  • ProShare Advisors reported no remaining Outset Medical position as of Q2 2022 after selling out during the quarter.
  • ProShare Advisors sold 586 Outset Medical shares in Q2 2022, an estimated $398K.
  • ProShare Advisors first reported a position in Outset Medical in Q2 2021 and held it in 4 quarters.
  • ProShare Advisors's Outset Medical position peaked at $593K in Q2 2021.
  • 149 funds tracked by Wall St. Rank held Outset Medical as of Q2 2022.

Based on ProShare Advisors's 13F filing for Q2 2022, filed 1 Aug 2022.